Michael Kramer | Feb 21, 2019 01:12AM ET
Despite the problems in Europe, the German DAX continues to rise and is nearing a potential break out should it rise above 11,535. It would likely send the index on to 11,891.
It seems hard to deny that no matter the troubles some of the economic indicators maybe flashing, stock markets continue to rise. The big question is whether it is part of a longer-term dead cat bounce or if it is a sign an improving global outlook?
The critical industrial metals such as copper have seen a massive move higher in recent weeks. All of the significant steps higher in the stock markets of global export economies and metals such as Copper and Platinum, are at least pointing to a hint of optimism taking hold suggesting that perhaps the worst of the economic slowdown is behind us.
The US equity market is pointing to a lower opening of about 1 point on the S&P 500. It continues to be my view that equity prices are due for a minor pullback. I think at this point; it is pretty safe to say that I’m obsessive over small details on daily movements of stock prices. However, it is just hard for me to ignore the glaring signs of a brief price decline that is in the works for stocks.
h2 NASDAQ (QQQ)/h2The NASDAQ fell below the rising wedge yesterday, and that would suggest there are still declines on the way, perhaps by as much as 2.5% to 7,300, allowing the index to fill the gap. Again, nothing major, but hard to ignore the possibility.
For now, a zone of support for the S&P 500 comes between 2,750 and 2,760.
Nike is pulling back some this morning after one if sneakers fell apart during the middle of an NCAA basketball. Support for the stock comes at roughly $81.50.
Amazon has struggled in recent days and continues to hug the $1,620 level. I’ve said it before, and I shall repeat it, I still think this one is heading lower with a target for $1,520.
Johnson and Johnson has been subpoenaed over its baby powder. The stock hit its resistance on at $136.75 and in the short-term, it could drop back to around $131.
Biogen was downgraded this morning to hold from buy at Stifel with a $346 price target. Overall there is a downtrend to this stock and drop to $310 seems to be the most likely path.
Facebook continues to work its way lower trying to fill the gap. The first stop on the chart is $157, and then $148.
Twitter is failing at resistance at $31.90, and that means it may be on its way to $30.20
Original post
/h2
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.